Published in J Cell Biochem on August 01, 2010
Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci (2011) 1.70
Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol (2011) 1.41
Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem (2010) 1.33
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS One (2011) 1.26
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 1.09
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99
Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther (2012) 0.95
Obesity Impairs Skeletal Muscle Regeneration Through Inhibition of AMPK. Diabetes (2015) 0.85
Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice. PLoS One (2014) 0.83
Leptin promotes fetal lung maturity and upregulates SP-A expression in pulmonary alveoli type-II epithelial cells involving TTF-1 activation. PLoS One (2013) 0.81
The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts. PLoS One (2014) 0.80
Leptin increases mitotic index and regeneration ratio in hepatectomized rats. Med Sci Monit Basic Res (2013) 0.80
Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol (2015) 0.79
Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep (2015) 0.79
Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells. Evid Based Complement Alternat Med (2016) 0.79
Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C. Transplantation (2014) 0.78
Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin. J Mol Endocrinol (2014) 0.78
Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury. Sci Rep (2016) 0.77
Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget (2016) 0.75
AMPK: a novel target for treating hepatic fibrosis. Oncotarget (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
Leptin and the regulation of body weight in mammals. Nature (1998) 14.84
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 14.15
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79
Identification and expression cloning of a leptin receptor, OB-R. Cell (1995) 9.74
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 8.95
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Adiponectin and adiponectin receptors. Endocr Rev (2005) 8.46
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest (2003) 5.32
Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84
Suppressors of cytokine signaling and immunity. Nat Immunol (2003) 3.68
Activation of downstream signals by the long form of the leptin receptor. J Biol Chem (2000) 3.52
The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A (1996) 3.21
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology (2002) 2.97
Intracellular signalling pathways activated by leptin. Biochem J (2006) 2.93
Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A (1996) 2.77
Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A (1996) 2.68
The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem (1999) 2.63
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation (2004) 2.58
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology (2003) 2.53
Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab (2006) 2.52
Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis (2001) 2.50
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr (2007) 2.40
Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology (2002) 2.34
Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem (1987) 2.31
Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology (2002) 2.10
A role for leptin and its cognate receptor in hematopoiesis. Curr Biol (1996) 1.99
Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol (2002) 1.86
Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem (2002) 1.86
Adiponectin and its receptors are expressed in bone-forming cells. Bone (2004) 1.86
Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol (2008) 1.84
Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology (2006) 1.81
Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE (2006) 1.79
In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology (2000) 1.66
Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes (2002) 1.65
Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta (2006) 1.56
The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem (2000) 1.53
The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol (2005) 1.49
Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem (2000) 1.46
Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem (2009) 1.44
Leptin and renal disease. Am J Kidney Dis (2002) 1.42
Leptin action in intestinal cells. J Biol Chem (1998) 1.41
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology (2008) 1.37
The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol (1997) 1.35
Nonalcoholic steatohepatitis. Semin Liver Dis (1999) 1.32
Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther (1993) 1.29
Hepatic fibrogenesis. Semin Liver Dis (2007) 1.27
Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem (1997) 1.22
Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem (2003) 1.19
The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol (2002) 1.16
Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells. J Hepatol (2006) 1.15
Adiponectin is present in human milk and is associated with maternal factors. Am J Clin Nutr (2006) 1.15
Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci U S A (2000) 1.14
Matrix metalloproteinases and oral cancer. Oral Oncol (1999) 1.11
Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol (2006) 1.09
AMP-activated protein kinase: Role in metabolism and therapeutic implications. Diabetes Obes Metab (2006) 1.07
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology (2008) 1.06
Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice. Lab Invest (2009) 1.05
Adiponectin, the controversial hormone. Public Health Nutr (2007) 1.05
CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem (2003) 1.04
Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum (2006) 1.02
Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem (2006) 1.01
AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity. Mol Cell Endocrinol (2008) 0.89
DLPC and SAMe combined prevent leptin-stimulated TIMP-1 production in LX-2 human hepatic stellate cells by inhibiting HO-mediated signal transduction. Liver Int (2006) 0.83
Leptin stimulates alpha1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway. Liver Int (2007) 0.81
Physiologic concentrations of leptin increase collagen production by non-immortalized human hepatic stellate cells. Metabolism (2006) 0.81
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res (2007) 2.50
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology (2007) 2.25
Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology (2002) 2.10
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology (2006) 2.08
Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila) (2012) 1.90
Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology (2010) 1.86
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology (2005) 1.81
An assessment of statin safety by hepatologists. Am J Cardiol (2006) 1.78
Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res (2008) 1.67
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res (2012) 1.65
An operational heat/health warning system in Shanghai. Int J Biometeorol (2003) 1.59
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res (2006) 1.58
The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol (2005) 1.49
leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem (2007) 1.48
Shanthi V. Sitaraman, MD, PhD: physician, scientist, educator, and humanitarian. Gastroenterology (2011) 1.39
Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem (2012) 1.37
Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol (2004) 1.32
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS One (2011) 1.26
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23
Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology (2010) 1.20
Epstein-Barr virus induced hepatitis: An important cause of cholestasis. Hepatol Res (2005) 1.20
Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem (2003) 1.19
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Development of a unique small molecule modulator of CXCR4. PLoS One (2012) 1.18
Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene (2004) 1.16
Med1 plays a critical role in the development of tamoxifen resistance. Carcinogenesis (2012) 1.13
Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol (2006) 1.09
Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr (2013) 1.07
Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver. Hepatology (2004) 1.06
Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension. Hypertension (2003) 1.05
Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis (2010) 1.04
Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocr Relat Cancer (2011) 1.01
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99
Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urol (2005) 0.97
Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids. Mol Biol Cell (2011) 0.95
Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res (2008) 0.94
Surface modification of poly (D,L-lactic acid) with chitosan and its effects on the culture of osteoblasts in vitro. J Biomed Mater Res (2002) 0.93
Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. Am J Hypertens (2005) 0.92
Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model. Hepatology (2014) 0.90
The SPLIT research agenda 2013. Pediatr Transplant (2013) 0.90
Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol (2010) 0.89
The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig Dis Sci (2013) 0.88
Poly(D,L-lactic acid) surfaces modified by silk fibroin: effects on the culture of osteoblast in vitro. Biomaterials (2002) 0.88
Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis. Am J Med (2002) 0.87
Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. Cancer Res (2014) 0.87
Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. Neoplasia (2013) 0.83
The role of gastrointestinal hormones in hepatic lipid metabolism. Semin Liver Dis (2013) 0.83
Contrast-Based Real-Time Assessment of Microcirculatory Changes in a Fatty Liver After Ischemia Reperfusion Injury. J Pediatr Gastroenterol Nutr (2016) 0.81
Treatment of fibrosis in nonalcoholic fatty liver disease. Curr Gastroenterol Rep (2007) 0.78
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Chlorzoxazone as a cause of acute liver failure requiring liver transplantation. Dig Dis Sci (2007) 0.77
Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat? Hepatology (2005) 0.77
Increased liver enzyme levels and HNF-1beta gene mutation. Clin Gastroenterol Hepatol (2008) 0.75
The Diabetes Prevention Program and the metabolic syndrome. Ann Intern Med (2005) 0.75
Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlight. Hepatology (2013) 0.75
Hepatorenal syndrome. Definition, pathophysiology, and intervention. Crit Care Clin (2002) 0.75
Recent changes in relationships between medical school physicians and industry. Gastroenterology (2010) 0.75